Autism (incidence)

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

WikiDoc Resources for

Autism (incidence)

Articles

Most recent articles on Autism (incidence)

Most cited articles on Autism (incidence)

Review articles on Autism (incidence)

Articles on Autism (incidence) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Autism (incidence)

Images of Autism (incidence)

Photos of Autism (incidence)

Podcasts & MP3s on Autism (incidence)

Videos on Autism (incidence)

Evidence Based Medicine

Cochrane Collaboration on Autism (incidence)

Bandolier on Autism (incidence)

TRIP on Autism (incidence)

Clinical Trials

Ongoing Trials on Autism (incidence) at Clinical Trials.gov

Trial results on Autism (incidence)

Clinical Trials on Autism (incidence) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Autism (incidence)

NICE Guidance on Autism (incidence)

NHS PRODIGY Guidance

FDA on Autism (incidence)

CDC on Autism (incidence)

Books

Books on Autism (incidence)

News

Autism (incidence) in the news

Be alerted to news on Autism (incidence)

News trends on Autism (incidence)

Commentary

Blogs on Autism (incidence)

Definitions

Definitions of Autism (incidence)

Patient Resources / Community

Patient resources on Autism (incidence)

Discussion groups on Autism (incidence)

Patient Handouts on Autism (incidence)

Directions to Hospitals Treating Autism (incidence)

Risk calculators and risk factors for Autism (incidence)

Healthcare Provider Resources

Symptoms of Autism (incidence)

Causes & Risk Factors for Autism (incidence)

Diagnostic studies for Autism (incidence)

Treatment of Autism (incidence)

Continuing Medical Education (CME)

CME Programs on Autism (incidence)

International

Autism (incidence) en Espanol

Autism (incidence) en Francais

Businness

Autism (incidence) in the Marketplace

Patents on Autism (incidence)

Experimental / Informatics

List of terms related to Autism (incidence)

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

See Autism for general information about autism. See Incidence (epidemiology) for information about incidence.

The reported incidence of autism varies considerably among countries and is complicated by varying criteria for diagnosing autism, different standards for reporting public health problems, and other possible variations.

Background

Autism was first characterised in 1943 by psychiatrist Dr. Leo Kanner of the Johns Hopkins Hospital in Baltimore, and almost simultaneously, in German, by Dr Hans Asperger. Both published case series of children with strikingly similar features.

The number of children born in each year diagnosed with autism in countries reporting figures is larger now than then. The populations of those countries have also increased but it is unclear what change in the incidence fraction has occurred. Public health organizations and researchers are not yet confident they have completely determined causes for all changes in the rate of reports of Autism (vide infra). Potential factors listed by the UK National Autistic Society include:[1]

  • The underlying condition may have a changing incidence with time, i.e., more children (and/or more per thousand born) are affected by it;
  • More complete pickup of autism (case finding), as a result of increased awareness and funding;
  • Attempts in the US and UK to sue vaccine companies may have also increased case-reporting.
  • The diagnosis being applied more broadly than before, as a result of the changing definition of the disorder, particularly changes in DSM-III-R;[1] and DSM-IV[1]
  • Successively earlier diagnosis in each succeeding cohort of children including recognition in nursery (preschool) - this would affect apparent prevalence but not incidence

There has been public concern that the MMR vaccine or the vaccine preservative thiomersal have contributed to an increase in the incidence of autism; the consensus of the medical and scientific community is that there is no scientific evidence to support these hypotheses,[1] but decreasing uptake of vaccines has led to outbreaks of serious childhood diseases.[1]

Incidence

The incidence of a condition is the rate at which new cases occur in a population during a specified interval, e.g. "10 per year" or "12 in 1982". The prevalence of a condition is the proportion of a population that are cases at a point in time, e.g. "1 in 1000".[1]

Examples of the way information is collected to specifically measure incidence rather than prevalence include:

  • Annual and age specific incidence for first recorded diagnoses of autism (that is, when the diagnosis of autism was first recorded);
  • Annual, birth cohort specific risk of autism diagnosed[1]

Incidence in sub-groups

There have been suggestions that the incidence of autism may vary amongst particular groups defined by occupation, lifestyle or genetic isolation. Changes that made travel and communication easier, and the growth of the technological industries during the past decade, have been suggested as means for increase in the proportion of couples likely to produce an autistic child. None of these have been established.[1][1][1][1]

Geographical incidence

Denmark

In November 2002, a study reported a lower incidence of autism in Denmark than in the US and other countries. An incidence of 1 in 727 (738 out of 537,303) was reported, compared with up to 1 in 86 among primary school children in the United Kingdom and around 1 in 150 children in the USA. Danish authorities also reported a continued increase in the incidence of autism after 1992 after withdrawal of thiomersal-containing vaccines.[1] Data presented in 2003 shows a clear increase in incidence between 1990 and 1995 (before the criteria changed). Thus, the increased incidence of autism after the removal of thiomersal was not a measurement artefact.[1]

Japan

The Yokohama study in Japan (2005) examined the incidence of autism before and after the 1993 withdrawal of MMR, reporting 48 and 86 cases per 10,000 children in two sequential years before withdrawal, doubling to 97 and 161 per 10,000 afterwards in the two years afterwards.[1][1]

It studied over 30,000 children (278 cases) born in one district of Yokohama.[1]

United Kingdom

The National Autistic Society regarded the incidence and changes in incidence with time as unclear.[1] A 2001 review,[1] by the Medical Research Council, yielded an estimate of one in 166 in children under eight.

The reported autism incidence in the UK rose starting before the first introduction of the MMR vaccine in 1989.[1]

United States

Reports of autism cases grew dramatically in the U.S. in 1996–2005. It is unknown how much, if any, growth came from changes in autism's prevalence.
Reports of autism cases grew dramatically in the U.S. in 1996–2005. It is unknown how much, if any, growth came from changes in autism's prevalence.

The number of diagnosed cases of autism grew dramatically in the U.S. in the 1990s and early 2000s. For example, in 1996, 21,669 children and students aged 6–11 years diagnosed with autism were served under Part B of the Individuals with Disabilities Education Act (IDEA) in the U.S. and outlying areas; by 2001 this number had risen to 64,094, and by 2005 to 110,529.[1]

Notes

37. Tebruegge M, Nandini V, Ritchie J. Does routine child health surveillance contribute to the early detection of children with pervasive developmental disorders? An epidemiological study in Kent, U.K. BMC Pediatr. 2004 Mar 3;4:4.

References

  • CPA-APC.org - Diagnosis and Epidemiology of Autism Spectrum Disorders Lee Tidmarsh, MD, Fred R Volkmar, MD, The Canadian Journal of Psychiatry, Vol 48 pp 517–525, 2003
  • NIH.gov - 'The changing prevalence of autism in California', L.A. Croen, J.K. Grether, J Hoogstrate, S Selvin, Journal of Autism Developmental Disorders Vol 32, No 3, pp 207-15, June, 2002
  • NIH.gov -'The epidemiology of autistic spectrum disorders: is the prevalence rising?', Lorna Wing, D. Potter, Ment Retard Dev Disabil Res Rev, Vol 8, No 3, pp 151-61, 2002
  • NIH.gov - 'The incidence of autism in Olmsted County, Minnesota, 1976-1997: results from a population-based study', W.J. Barbaresi, S.K Katusic, R.C. Colligan, A.L. Weaver, S.J. Jacobsen, Arch Pediatr Adolesc Med, Vol 159, No 1, pp 37-44, January, 2005
  • California DDS figures and reports: http://www.dds.ca.gov/FactsStats/quarterly.cfm , http://www.dds.ca.gov/autism/autism_main.cfm

External links

  • Wired.com - 'The Geek Syndrome: Autism - and its milder cousin Asperger's syndrome - is surging among the children of Silicon Valley. Are math-and-tech genes to blame?' Steve Silberman Wired (December, 2001)
WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools